Effects of peptidase inhibitors on the Enkephalin-induced anti-nociception in rats

Japanese Journal of Pharmacology

Volumn 78, Issue 4, 1998, Pages 487-492

  Taniguchi, Takao ^a   Fan, Xin Tian ^a   Kitamura, Ken ^a   Oka, Tetsuo ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Amastatin; Anti nociception; Captopril; Phosphoramidon; Met5 enkephalin

Indexed keywords

AMASTATIN; CAPTOPRIL; ENKEPHALIN; ENZYME INHIBITOR; METENKEPHALIN; MORPHINE; PEPTIDASE; PHOSPHORAMIDON;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG HYDROLYSIS; DRUG POTENCY; ENZYME INHIBITION; GUINEA PIG; ILEUM; MALE; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

EID: 0032406901     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.78.487     Document Type: Article

References (25)

1. Aoki K, Kajiwara M and Oka T: The role of bestatin-sensitive aminopeptidase, angiotensin converting enzyme and thiorphan-sensitive "enkephalinase" in the potency of enkephalins in the guinea-pig ileum. Jpn J Pharmacol 36, 59-65 (1984)
2. 5]-enkephalin by bestatin-sensitive aminopeptidase, captopril-sensitive peptidyl dipeptidase A and thiorphan-sensitive endopeptidase-24.11 in mouse vas deferens. Jpn J Pharmacol 40, 297-302 (1986)
3. 5]-enkephalin in rat vas deferens. Jpn J Pharmacol 42, 43-49 (1986)
4. Kuno Y, Aoki K, Kajiwara M, Ishii K and Oka T: The relative potency of enkephalins and β-endorphin in guinea-pig ileum, mouse vas deferens and rat vas deferens after the administration of peptidase inhibitors. Jpn J Pharmacol 41, 273-281 (1986)
5. 6 in three isolated preparaions by employing the inhibitor specific for each enzyme. Jpn J Pharmacol 44, 241-247 (1987)
6. 5]-enkephalin hydrolysis in ileal and striatal preparations of guinea-pig: almost complete protection of degradation by the combination of amastatin, captopril and thiorphan. Jpn J Pharmacol 41, 437-446 (1986)
7. 5)-enkephalin analgesia by captopril. Brain Res 188, 295-299 (1980)
8. 7 by inhibiting its degradation in mouse brain. Mol Pharmacol 28, 521-526 (1985)
9. Costentin J, Vlaiculescu A, Chaillet P, Natan LB, Aveaux D and Schwartz JC: Dissociated effects of inhibitors of enkephalin-metabolising peptidases or naloxone on various nociceptive responses. Eur J Pharmacol 123, 37-44 (1986)
10. 5]enkephalin levels and jump latency in mouse hot plate test. Eur J Pharmacol 154, 319-324 (1988)
11. Oka T, Liu XF, Kajita T, Ohgiya N, Ghoda K, Taniguchi T, Arai Y and Matsumiya T: Effects of the subcutaneous administration of enkephalins on tail-flick response and righting reflex of developing rats. Dev Brain Res 69, 271-276 (1992)
12. Paxinos G and Watson C: The Rat Brain in Stereotaxic Coordinates. Academic Press, New York (1986)
13. Janssen PAJ, Niemegeers CJE and Dony JGH: The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex. Arzneimittelforschung 13, 502-504 (1963)
14. Lord JAH, Waterfield AA, Hughes J and Kosterlitz HW: Endogenous opioid peptides: multiple agonists and receptors. Nature 267, 495-499 (1977)
15. Portoghese PS, Sultana M and Takemori AE: Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur J Pharmacol 146, 185-186 (1988)
16. Chaillet P, Coulaud A, Zajac JM, Fournie-Zaluski MC, Costentin J and Roques BP: The μ rather than the δ subtype of opioid receptors appears to be involved in enkephalin-induced analgesia. Eur J Pharmacol 101, 83-90 (1984)
17. Kishioka S, Miyamoto Y, Fukunaga Y, Nishida S and Yamamoto H: Effects of a mixture of peptidase inhibitors (amastatin, captopril and phosphoramidon) on Met-enkephalin-, β-endorphin-, dynorphin-(1-13)- and electroacupuncture-induced antinociception in rats. Jpn J Pharmacol 66, 337-345 (1994)
18. 8 (met-enk-RGL) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon. J Pharmacol Exp Ther 281, 769-774 (1997)
19. Cohen ML and Kurz KD: Angiotensin-converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421. J Pharmacol Exp Ther 220, 63-69 (1982)
20. 7 and other opioid peptides. Naunyn Schmiedebergs Arch Pharmacol 357, 276-282 (1998)
21. Hiranuma T, Kitamura K, Taniguchi T, Kanai M, Arai Y, Iwao K and Oka T: Protection against dynorphin-(1-8) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon. J Pharmacol Exp Ther 286, 863-869 (1998)
22. Matsas R, Rattray M, Kenny AJ and Turner AJ: The metabolism of neuropeptides: endopeptidase-24.11 in human synaptic membrane preparations hydrolyses substance P. Biochem J 228, 487-492 (1985)
23. Hooper NM, Kenny AJ and Turner AJ: The metabolism of neuropeptides: neurokinin A (substance K) is a substrate for endopeptidase-24.11 but not for peptidyl dipeptidase A (angiotensin-converting enzyme). Biochem J 231, 357-361 (1985)
24. 8. FEBS Lett 175, 124-128 (1984)
25. Checler F, Vincent JP and Kitabgi P: Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin like metalloendopeptidase (enkephalinase), angiotensin converting enzyme, and other unidentified peptidases. J Neurochem 41, 375-384 (1983)